1.

Introduction
Kidney transplantation (KT) is considered the preferred treatment for patients with end-stage renal disease (ESRD) owing to the greater survival rate and better quality of life in comparison to hemodialysis [1] . Although the open approach remains the gold standard, minimally invasive techniques have been introduced to decrease the morbidity and mortality of open surgery [2] , which could be especially important in immunocompromised and fragile KT patients. In 2002 Hoznek et al [3] described the possibility of performing a robotic anastomosis in KT, and in 2010 the first pure RAKT was performed by Giulianotti et al [4] in the USAs. One of the major challenges in RAKT was to keep the kidney cool during vascular anastomosis. Therefore, in 2014 Menon et al [5] standardized the technique with the transperitoneal approach and regional hypothermia. The authors highlighted that RAKT is a safe technique with possible advantages such as low intra-and postoperative complications, better cosmetic results, and superlative vision that could result in better quality of the vascular and ureteral anastomoses. In Europe, the first RAKT was performed by Boggi et al [6] in 2011 as a hybrid case with robotic vascular anastomosis and open ureterovesical anastomosis. The first two European pure RAKTs were performed in July 2015 by Doumerc et al [7] and Breda et al [8] . A year later, Breda et al [9] reported surgical and functional outcomes for 17 patients undergoing RAKT. Starting from these preliminary pure RAKT results, a European Robotic Urological Society (ERUS) RAKT group was created with the aim of collecting prospective data on RAKT in a common database.
The primary objective of this study was to evaluate perioperative and early postoperative surgical outcomes for RAKT performed in eight European institutions. Secondary objectives included functional outcomes and correlations between surgical data and functional results.
2.
Patients and methods
Study design
This was a multicenter prospective observational study on RAKT predominantly from living donors performed at eight European centers (Table 1) . The project was integrated in the ERUS RAKT working group to collect prospective data on RAKT. 
Study sample
Study variables and outcomes
Data for sociodemographic variables, surgical and functional outcomes, and early postoperative complications with minimum follow-up of 1 mo were prospectively collected.
The surgical outcomes evaluated included cold and warm ischemia time and rewarming time. Warm ischemia time is the period between renal circulatory arrest and the beginning of cold storage; cold ischemia time is the duration of cold storage, with or without perfusion with a storage solution, before introduction of the graft into the recipient.
Rewarming time is the time between removal of the kidney from cold storage and the start of reperfusion while continuously adding ice slush.
Other surgical data analyzed were overall operative time, console time, The functional outcomes considered were serum creatinine and estimated GFR (eGFR) on postoperative day (POD) 1, 3, 7, and 30. eGFR was calculated using the Modified Diet in Renal Disease equation (patient >18 yr old) [11, 12] . Delayed graft function (DGF) was considered as a need for dialysis in the first postoperative week. Among the functional outcomes, we also included postoperative hemoglobin, evaluation of postoperative pain using a visual analog score (VAS), postoperative hospitalization, and time to double-J removal.
Surgical procedure (Si/Xi da Vinci)
The first standardization of RAKT was described by Menon et al [5] in the IDEAL phase 2a study. Following this technique, Breda et al [9] reported their first RAKT results with details of the technical aspects and surgical steps. The possible transvaginal introduction route has been described by Doumerc et al [8] . 
Surgical experience
All surgical teams involved in this study have thorough expertise in the field of robot-assisted surgery and open KT, with several hundred procedures of each approach performed. Before starting on human subjects, all the surgeons involved had extensively rehearsed the technique on animal models, with proctoring by a more experienced RAKT surgeon during training and when performing the first case(s) in their own center following the standardized approach mentioned above.
Statistical analysis
Data for the demographic characteristics and comorbidities of recipients and for donor characteristics were recorded in a common database.
Qualitative variables were described using absolute frequencies and percentages. Quantitative variables were described using the mean, standard deviation (SD), median, and quartiles. The KolmogorovSmirnov test was used to assess the normality of distributions.
Linear relationships between surgical variables (operative and ischemia times) and biomarkers (creatinine [mmol/l and eGFR
) were analyzed using the Pearson test. Follow-up changes in biomarkers were also calculated and analyzed using a Wilcoxon test. Surgical variables were transformed as ordinal variables using tercile values and were compared with biomarkers using a Mann-Whitney U test. For all tests, p < 0.05 was considered statistically significant. The statistical package R-Studio (V 3.5) was used for statistical analyses.
Results
Descriptive characteristics
A total of 120 patients were recruited. Demographic data and graft characteristics are summarized in Table 2 .
Surgical data and functional results
Surgical data are reported in Table 3 . The median estimated blood loss was 150 ml, with median hemoglobin of 110 mg/dl preoperatively and 101, 95 and 98 mg/dl on POD 1, 3, and 7, respectively. Two patients were converted to [ open transplantation owing to low blood flow at Doppler ultrasound evaluation immediately after skin closure and they account for the longest operative times. Preoperative functional data and postoperative functional results in terms of creatinine and eGFR on POD 1, 3, 7, and 30 are summarized in Table 4 . A significant improvement in renal function (serum creatinine and eGFR) was observed progressively at all postoperative time points. We could not find a correlation between total operative time or rewarming time and postoperative creatinine or eGFR (Tables 5 and 6 ).
The median VAS pain score was 5, 4, 3, and 2 at 12, 24, 36, and 48 h, after surgery. The median hospital stay was 7 d (range 4-8 d). The median double-J dwell time was 28 d (range 14-60). Five cases (4.2%) of DGF were reported. No arterial or ureteral strictures occurred. 3.3.
Postoperative complication rate
Postoperative complications, recorded according to the Clavien-Dindo classification, are summarized in Table 7 . One case (0.8%) of wound infection, three cases (2.5%) of ileus, and four cases (3.3%) of bleeding (three of which required 
blood transfusion), managed conservatively, were observed. One case (0.8%) of deep venous thrombosis required anticoagulant drugs. One case (0.8%) of lymphocele required percutaneous drainage. Three cases (2.5%) of transplantectomy due to massive arterial thrombosis were recorded. In five cases (4.2%), surgical exploration was performed for intraperitoneal hematoma (on POD 2 in 2 cases, POD 3 in 2 cases, and POD 4 in 1 case). None of the patients experienced more than one complication.
Discussion
Patients with ESRD are generally immunocompromised and fragile. Accordingly, they may gain significant benefits from KT performed using a minimally invasive approach. Minimally invasive techniques in KT (laparoscopic and robotic approaches) have recently been introduced to increase perioperative and postoperative benefits such as shorter hospital stay, minimal postoperative pain, shorter convalescence period, fewer wound infections, and better cosmetic results, as observed for minimally invasive radical prostatectomy [2] . Following the first European experience in RAKT [7, 8] , the robotic approach in KT is now performed in a few European centers as an alternative to the open approach in selected patients. To date, 120 RAKTs, mainly from living donors (98%), have been performed in this prospective nonrandomized pilot study. Surgical aspects, functional outcomes, and postoperative complication rates were evaluated in this series, which, to the best of our knowledge, is the largest reported on RAKT.
Regarding the surgical aspects, our multicenter prospective study confirms that RAKT can be performed by surgeons with extensive experience in robotic and transplant surgery, even in the early stages of their learning curve. We would like to stress that to obtain such results, the eight surgeons (15) were trained in an animal laboratory before starting RAKT in humans. Furthermore, the surgeons were proctored during their first four cases to reduce possible mistakes during their learning curve. In terms of functional outcomes, the most important aspect to consider in KT performed from living donors is patient and graft survival. In a recently published systematic review, no significant differences were observed between the different approaches used (open, laparoscopic, and robotic) in terms of patient and graft survival [13] . For open KT the rate of DGF from living donors has been reported to be up to 4% [14] , while the reported prevalence of arterial graft thrombosis is between 0.5% and 3.5% [15] . In our multicenter study, we observed five cases (4.2%) of DGF and three cases (2.5%) of arterial thrombosis with graft loss. These results are in line with the literature on open KT, although we note that they could also be related to a learning curve process (with possible technical mistakes) as the lost grafts were at the beginning of the RAKT program. However, the safety of the procedure and graft outcome should be guaranteed even during the learning curve. Therefore, proctoring and careful patient selection (eg, suitable BMI and no previous abdominal surgery) are important during the learning phase. It is important to emphasize that a high level of expertise is required in KT and robotic surgery [16] . Theoretically, particularly during the learning curve, performing RAKTs from deceased donors would possibly reduce the stress related to the surgery. However, recipients of kidneys from deceased donors have a high incidence of arterial atherosclerosis that can potentially compromise arterial clamping and/or vascular anastomosis during this phase. Another important aspect to consider is that it is crucial for success that the surgery always has to be performed by the same dedicated team. This would be very difficult to achieve at times for deceased donor transplantation (ie, night shifts, difficulty in using the robot at night).
So far, it is not completely known whether the intraabdominal temperature during vascular anastomosis has a potentially detrimental effect. When using the robotic approach, maintaining a constant low temperature during the rewarming time is a challenge. The impact of potentially longer duration of rewarming during RAKT on graft function remains unclear [17] . However, to avoid graft impairment during the rewarming time, a regional hypothermia technique for RAKT was described by Menon et al [5] in their IDEAL phase 2a study. The authors reported use of a gauze jacket filled with ice slush to wrap the kidney during vascular anastomosis, with continuous addition of ice slush for intraperitoneal cooling of the graft. The limitation of this cooling device is the gradual intra-abdominal melting of ice, which might result in renal allograft impairment when there is an extended vascular anastomosis time. Even though it has been confirmed by other authors that this technique is safe and effective [8, 18] , many concerns remain regarding local and possibly systemic complications related to the use of intraperitoneal cooling to maintain the graft at a constant low temperature. Tu gcu et al [19] reported paralytic ileus as a complication of the use of ice slush, and no ileus occurred when the amount of ice slush was decreased. The three cases of ileus (2.5%) that we observed could also have been caused by intraperitoneal ice cooling.
The potential damage to the graft as a result of pneumoperitoneum and the associated increase in intraabdominal pressure is not fully known. According to the literature, both renal function and renal blood flow are decreased during pneumoperitoneum, potentially leading to graft impairment. The extent of these reductions depends on preoperative renal function, hydration, and pneumoperitoneum pressure and duration [20] .
In our series, we described a wide range of both overall operative and ischemia times. This reflects the different learning curves of the surgeons as well as the time loss for open conversion in two cases and the presence of two deceased donors in our series. Furthermore, we could not find a correlation between operative time (including graft exposure to pneumoperitoneum) or rewarming time and graft function (Tables 5 and 6 ).
In general, the typical technical advantages of robotic surgery are related to the use of articulated instruments, a three-dimensional view, superb magnification (12Â), and good surgeon ergonomics. Furthermore, correct use of the da Vinci robotic system possibly provides benefits in terms of patient outcomes, including a significant decrease in blood loss, a low postoperative complication rate, and shorter hospital stay [21] . Oberholzer et al [22] showed the advantages of RAKT in an obese population; from a technical point of view, as reported by Breda et al [7, 9] , other advantages of RAKT are related to the quality of the vascular anastomosis.
According to a recently published systematic review, minimally invasive techniques in KT, including RAKT, have shown promising results, particularly with regard to complications and recovery [13] . In terms of complications, our experience is in line with that in other RAKT series reported [5] . Unlike open KT [23] , lymphocele is an uncommon complication in RAKT. The intraperitoneal window left during RAKT allows natural drainage of lymph into the peritoneal space. In addition, the wound infection rate seems to be very low, with only one case (0.8%) reported in a patient with diabetes and hypertension.
Sood et al [18] reported that RAKT is a safe surgical alternative to open KT, reducing postoperative pain and analgesic requirement with a better cosmetic result (Fig. 6) . We also observed a low postoperative VAS pain score that rapidly decreased, with a mean hospital stay of 6 AE1 d. Length of hospital stay may be considered another possible advantage of RAKT compared to the mean stay for open series (9 AE 7 d) [24] .
One of the limitations of the present study is possible bias in the selection process. The eight centers included in the study are high-volume centers. Despite this, a limited number of recipients were included in the study. This can be explained not only by the inclusion and exclusion criteria but also by the cost limitations of the procedure (some centers had a limited number of procedures accepted per year) and patient preference. Furthermore, not all centers started to recruit patients at the same time. Another limitation is the failure to report cosmetic outcomes in a uniform manner. For this reason, no adequate conclusions can be drawn regarding patients' cosmetic satisfaction. From the point of view of cosmetics and postoperative recovery, the transvaginal graft introduction technique described by Doumerc et al [8] and used in our series in four cases (Fig. 2 ) may be considered an optimal alternative in female recipients. A further limitation of our study is the lack of a control group of patients who underwent open KT from a living donor. A randomized controlled trial and longer follow-up would permit establishment of RAKT as an alternative to open KT.
Conclusions
To the best of our knowledge, this is the first and largest reported multicenter prospective study on RAKT. In our European patient group, RAKT has been proven to be an advanced application for KT. Surgical data show that RAKT is safe, feasible, and reproducible when performed by surgeons with experience in both robotic and KT surgery. Use of a robotic technique also has low complication rates in selected cases and yields excellent graft function.
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